Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ENALAPRIL vs ENCORAFENIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ENALAPRIL vs ENCORAFENIB: Safety Overview

Metric ENALAPRIL ENCORAFENIB
Total FAERS Reports 7,730 8,554
Deaths Reported 711 1,397
Death Rate 9.2% 16.3%
Hospitalizations 3,919 2,334
Average Patient Age 63.5 yrs 64.4 yrs
% Female Patients 49.3% 50.9%
FDA Approval Date Aug 10, 2021 Jun 27, 2018
Manufacturer Bionpharma Inc. Array BioPharma Inc.
Route ORAL ORAL
Marketing Status Prescription Discontinued